Nicole G Jaff1, Tracy Snyman, Shane A Norris, Nigel J Crowther. 1. From the 1Medical Research Council/Developmental Pathways for Health Research Unit, University of the Witwatersrand, Johannesburg, South Africa; and 2Department of Chemical Pathology, National Health Laboratory Service and University of the Witwatersrand, Johannesburg, South Africa.
Abstract
OBJECTIVE: There has been limited research on accurate staging of the menopausal transition in sub-Saharan African women. Our aim was to assess the usefulness of the Stages of Reproductive Aging Workshop + 10 (STRAW + 10) criteria in staging ovarian aging in black South African women, examining whether obesity has any effect on the menopausal transition. METHODS: The study enrolled 702 women aged 40 to 60 years. STRAW + 10 criteria were used to categorize the stages of reproductive aging. The Menopause Rating Scale was used to measure the prevalence of vasomotor symptoms. Follicle-stimulating hormone (FSH) and estradiol levels were used as supportive criteria for staging. Human immunodeficiency virus status was assessed using a point-of-care method. RESULTS: Reported age at final menstrual period (FMP) was higher in women interviewed within 4 years of FMP (mean [SD], 49.0 [3.80] y) than in women interviewed 10 years or more after FMP (mean [SD], 42.0 [4.06] y; P < 0.0005). In women within 4 years of FMP, lower body mass index was associated with earlier age at FMP. FSH levels increased and estradiol levels decreased (P < 0.0005 for both trends) across seven staging groups. Human immunodeficiency virus status had no effect on menopause symptoms. Obesity (body mass index ≥35.0 kg/m) was associated with severe vasomotor symptoms. CONCLUSIONS: Reporting of age at FMP is unreliable in women interviewed 4 years or more after the event. STRAW + 10 seems accurate in staging reproductive aging, as confirmed by the strong association of FSH and estradiol levels with the menopausal transition stage. STRAW + 10 may be appropriate for use in resource-limited settings in the absence of biomarkers. Biocultural methods may be useful in assessing the menopausal transition in culturally diverse women.
OBJECTIVE: There has been limited research on accurate staging of the menopausal transition in sub-Saharan African women. Our aim was to assess the usefulness of the Stages of Reproductive Aging Workshop + 10 (STRAW + 10) criteria in staging ovarian aging in black South African women, examining whether obesity has any effect on the menopausal transition. METHODS: The study enrolled 702 women aged 40 to 60 years. STRAW + 10 criteria were used to categorize the stages of reproductive aging. The Menopause Rating Scale was used to measure the prevalence of vasomotor symptoms. Follicle-stimulating hormone (FSH) and estradiol levels were used as supportive criteria for staging. Human immunodeficiency virus status was assessed using a point-of-care method. RESULTS: Reported age at final menstrual period (FMP) was higher in women interviewed within 4 years of FMP (mean [SD], 49.0 [3.80] y) than in women interviewed 10 years or more after FMP (mean [SD], 42.0 [4.06] y; P < 0.0005). In women within 4 years of FMP, lower body mass index was associated with earlier age at FMP. FSH levels increased and estradiol levels decreased (P < 0.0005 for both trends) across seven staging groups. Human immunodeficiency virus status had no effect on menopause symptoms. Obesity (body mass index ≥35.0 kg/m) was associated with severe vasomotor symptoms. CONCLUSIONS: Reporting of age at FMP is unreliable in women interviewed 4 years or more after the event. STRAW + 10 seems accurate in staging reproductive aging, as confirmed by the strong association of FSH and estradiol levels with the menopausal transition stage. STRAW + 10 may be appropriate for use in resource-limited settings in the absence of biomarkers. Biocultural methods may be useful in assessing the menopausal transition in culturally diverse women.
Authors: Cindy George; Julia H Goedecke; Nigel J Crowther; Nicole G Jaff; Andre P Kengne; Shane A Norris; Lisa K Micklesfield Journal: PLoS One Date: 2016-05-12 Impact factor: 3.240
Authors: Jaya A George; Jean-Tristan Brandenburg; June Fabian; Nigel J Crowther; Godfred Agongo; Marianne Alberts; Stuart Ali; Gershim Asiki; Palwende R Boua; F Xavier Gómez-Olivé; Felistas Mashinya; Lisa Micklesfield; Shukri F Mohamed; Freedom Mukomana; Shane A Norris; Abraham R Oduro; Cassandra Soo; Hermann Sorgho; Alisha Wade; Saraladevi Naicker; Michèle Ramsay Journal: Lancet Glob Health Date: 2019-12 Impact factor: 26.763
Authors: Clement N Kufe; Lisa K Micklesfield; Maphoko Masemola; Tinashe Chikowore; Andre P Kengne; Fredrik Karpe; Shane A Norris; Nigel J Crowther; Tommy Olsson; Julia H Goedecke Journal: Eur J Endocrinol Date: 2022-03-23 Impact factor: 6.558
Authors: Stuart A Ali; Cassandra Soo; Godfred Agongo; Marianne Alberts; Lucas Amenga-Etego; Romuald P Boua; Ananyo Choudhury; Nigel J Crowther; Cornelius Depuur; F Xavier Gómez-Olivé; Issa Guiraud; Tilahun N Haregu; Scott Hazelhurst; Kathleen Kahn; Christopher Khayeka-Wandabwa; Catherine Kyobutungi; Zané Lombard; Felistas Mashinya; Lisa Micklesfield; Shukri F Mohamed; Freedom Mukomana; Seydou Nakanabo-Diallo; Hamtandi M Natama; Nicholas Ngomi; Engelbert A Nonterah; Shane A Norris; Abraham R Oduro; Athanase M Somé; Hermann Sorgho; Paulina Tindana; Halidou Tinto; Stephen Tollman; Rhian Twine; Alisha Wade; Osman Sankoh; Michèle Ramsay Journal: Glob Health Action Date: 2018 Impact factor: 2.640